Drug intelligence / Profile preview

IG-Stone Syrup

Development stage: Unknown
Lead developer: IGP Mediventures
Administration: Oral

Overview

IG-Stone Syrup is a polyherbal nutraceutical supplement developed by IGP Mediventures, primarily marketed for the management and relief of kidney stones (urolithiasis). As a product of an e-commerce wellness brand rather than a traditional pharmaceutical pipeline, it is formulated with botanical extracts traditionally used in Ayurvedic medicine to support renal health and facilitate the natural passage of urinary calculi. It is typically sold as a standalone syrup or as part of a comprehensive kidney stone relief kit. The formulation is intended to act as a lithontriptic and diuretic agent to assist in the dissolution and excretion of stones from the urinary tract.

Brand names: IG-Stone Syrup
Other names: IG-Stone Syrup

Beyond the preview

Go deeper on IG-Stone Syrup.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on IG-Stone Syrup.

Explore the full profile